Results 211 to 220 of about 1,082,361 (305)

Do psychotropic drugs cause seizures? [PDF]

Epilepsy Behav Rep
Gopaul M, Altalib H.
europepmc   +1 more source

Psychotropic drugs. [PDF]

BMJ, 1987
openaire   +2 more sources

Insights into Euphorbia diversity: Probing the contrasts between Euphorbia fischeriana Steud and Euphorbia ebracteolata Hayata

Journal of Pharmaceutical Analysis
Kaicheng Du, Yi Zhang, Lei Sun, Muke Tao, Tiantian Zuo, Yumeng Wang, Zhengfeng Zhang, Dali Meng   +7 more
doaj   +1 more source

From emergence to replacement: The evolution of 3‐methylmethcathinone (3‐MMC) and its substitutes in the Dutch drug market (2012–2024)

Addiction, EarlyView.
Abstract Background and aims The market for new psychoactive substances (NPS) is highly dynamic, with hundreds of substances emerging on the European drug market in the last decade. 3‐methylmethcathinone (3‐MMC), a synthetic cathinone and isomer of mephedrone (4‐MMC), gained popularity in the Netherlands due to its psychostimulant effects and initial ...
Nadia Robert Petronella Wilhelmina Hutten, Pieter Edmond Oomen, Frederiek Schutten, Margriet Walburga van Laar, Laura Alexandra Smit‐Rigter   +4 more
wiley   +1 more source

The association between job loss and alcohol and tobacco use

Addiction, EarlyView.
Abstract Aims This study used Australian longitudinal data to examine the effect of being fired or made redundant on alcohol and tobacco use. Design and setting Fixed effect panel analyses of 19 waves of the Household Income and Labour Dynamics in Australia (HILDA) survey, a voluntary representative longitudinal survey of over 17 000 Australians ...
Don Weatherburn, Sergey Alexeev
wiley   +1 more source

Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs. [PDF]

Biomed Rep
Zhou S, Hu X, Zhou P, Si J, Jiang Y.
europepmc   +1 more source

Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy

Addiction, EarlyView.
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, James J. Rucker, Anthony Cleare, John Marsden   +6 more
wiley   +1 more source

Use of sensing technologies to assess sleep quality and physical activity levels in nursing home residents with dementia taking nightly psychotropic drugs for sleep disturbance: a cross-sectional study. [PDF]

Front Aging
Boyle LD, Marty B, Haugarvoll K, Steihaug OM, Husebo BS.   +4 more
europepmc   +1 more source

Cannabis use disorder in patients prescribed medical cannabis—Should we consider prescription cannabis use disorder as a new diagnostic condition?

Addiction, EarlyView.
Abstract Background and Aims The introduction of prescribed medical cannabis in many parts of the world raises issues regarding how we conceptualise Cannabis Use Disorders (CUD). The Diagnostic Statistical Manual Version 5 (DSM5) provides a framework for ‘Prescription Cannabis Use Disorder’ (Pr‐CUD) when a person is using medical cannabis only‐as ...
Nicholas Lintzeris, Llewellyn Mills
wiley   +1 more source

Initiation and Discontinuation of Psychotropic Drugs Relative to Suicidal Behavior: A Danish Registry-Based Study. [PDF]

Acta Psychiatr Scand
Reilev M, Andersen JH, Højlund M, Stenager E, Rasmussen L, Christiansen E.   +5 more
europepmc   +1 more source